文献速递腹部技术与安全CT

淋巴瘤脾浸润与肝硬化脾肿大及正常对照脾脏的CT纹理特征鉴别及其在淋巴瘤纵向监测中的作用评价

Discriminatory CT-textural features in splenic infiltration of lymphoma versus splenomegaly in liver cirrhosis versus normal spleens in controls and evaluation of their role for longitudinal lymphoma monitoring.
PubMed 文献 · Eur J Radiol · 2018-05-12

回顾性纳入2013年8月至2017年10月间行腹部增强CT的淋巴瘤弥漫脾浸润29例、肝硬化30例和健康对照15例,比较脾脏CT纹理分析特征。淋巴瘤治疗前后及与对照间多项纹理值差异显著,完全缓解后与对照无显著差异,提示CT纹理特征可用于鉴别脾肿大病因并监测淋巴瘤治疗。

要点

  • 淋巴瘤脾浸润与健康对照的脾CT纹理值在平均强度、平均均值、偏差熵上差异显著。
  • 淋巴瘤治疗后脾纹理值较基线显著变化,完全缓解后与对照无显著差异。
  • 未治疗淋巴瘤与肝硬化脾肿大的平均强度和平均均值差异显著,有助于鉴别病因。

核心结论

  • 淋巴瘤所致脾肿大与肝硬化脾肿大的CT纹理分析特征与健康对照显著不同,并可用于监测淋巴瘤治疗;定量CT纹理特征可能提高脾肿大病因诊断的准确性。

研究设计与样本

  • 回顾性研究,2013年8月至2017年10月行腹部增强CT的74例受试者,包括淋巴瘤弥漫脾浸润29例、肝硬化30例、健康对照15例;CT纹理分析评估异质性、强度、平均值、偏差、偏度、共生熵、非均匀性数目(NGLDM)和熵NGLDM;以化疗后脾体积缩小大于50%作为脾浸润的证据。

诊断标准与关键数值

  • 淋巴瘤治疗前后脾CT纹理值有显著差异:熵均值p < .001、平均均匀性p < .001、偏差均匀性p = .002、偏度熵p < .001。淋巴瘤与健康对照间平均强度p < .001、平均均值p < .001、偏差熵p < .001差异显著。淋巴瘤完全缓解者与对照间脾CT纹理值无显著差异。未治疗淋巴瘤与肝硬化间平均强度p = .002、平均均值p = .004差异显著。治疗结束时全部淋巴瘤达完全缓解,此时异质性熵/均匀性p < .001、平均强度p = .007、平均均值p = .007、平均均匀性p = .008、偏度均值/熵/均匀性p = .001均与基线显著不同。

临床应用与阅片要点

  • 原文结论认为定量CT纹理特征可能提高脾肿大病因诊断的准确性,并可用于监测淋巴瘤治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To find CT-texture analysis (CTTA) features for the discrimination of splenomegaly due to diffuse lymphoma involvement and liver cirrhosis versus normal-sized spleens in controls and to assess their potential role for longitudinal lymphoma monitoring.

MATERIAL AND METHODS: We had retrospectively identified 74 subjects with diffuse splenic involvement due to lymphoma (n = 29) and liver cirrhosis (n = 30), and healthy controls (n = 15), who underwent contrast-enhanced abdominal CT between August 2013 and October 2017. CTTA evaluation included heterogeneity, intensity, average, deviation, skewness, entropy of co-occurrence, number non-uniformity (NGLDM) and entropy NGLDM. A greater than 50% reduction of spleen volume after chemotherapy was considered proof for splenic involvement.

RESULTS: There were significant differences of splenic CTTA-values before and after treatment of patients with lymphoma, including mean of entropy(p < .001), uniformity of average(p < .001), uniformity of deviation(p = .002) and entropy of skewness(p < .001). Significant differences of splenic CTTA-values in subjects with lymphoma vs. healthy controls were found for mean intensity(p < .001), mean average(p < .001), and entropy of deviation(p < .001). No significant differences in splenic CTTA-values were found in subjects with lymphoma that reached complete remission vs. controls. Splenic CTTA values mean intensity(p = .002) and mean average(p = .004) were significantly different between subjects with untreated lymphoma and subjects with liver cirrhosis. At end-of-treatment all lymphomas reached complete remission. Entropy/uniformity of heterogeneity(p < .001), mean intensity(p = .007), mean average (p = .007), uniformity of average(p = .008) and mean/entropy/uniformity of skewness(p = .001) measured at this time differed significantly from baseline.

CONCLUSIONS: CTTA features in subjects with splenomegaly due to lymphoma and liver cirrhosis differ significantly from those of healthy controls and can be also used for monitoring lymphoma treatment. Quantitative CTTA features may increase the accuracy of diagnosing causes of splenomegaly.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Reinert CP, Kloth C, Fritz J, et al. Discriminatory CT-textural features in splenic infiltration of lymphoma versus splenomegaly in liver cirrhosis versus normal spleens in controls and evaluation of their role for longitudinal lymphoma monitoring. Eur J Radiol. 2018. PMID: 29857858. doi:10.1016/j.ejrad.2018.05.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。